Karimi, F. and Arya, A. 2023. SGLT2 Inhibitor-Induced Ketonemia and Its Related Metabolic and Anti-Inflammatory Impacts in Adult Patients with Type 2 Diabetes: SGLT2 inhibitor-induced ketonemia in type 2 diabetes. Iranian Journal of Pharmaceutical Sciences. 19, 2 (Apr. 2023), 176–187. DOI:https://doi.org/10.22037/ijps.v19i2.42072.